Cargando…
Risk Factors for Cisplatin-Induced Nephrotoxicity and Potential of Magnesium Supplementation for Renal Protection
BACKGROUND: Nephrotoxicity remains a problem for patients who receive cisplatin chemotherapy. We retrospectively evaluated potential risk factors for cisplatin-induced nephrotoxicity as well as the potential impact of intravenous magnesium supplementation on such toxicity. PATIENTS AND METHODS: We r...
Autores principales: | Kidera, Yasuhiro, Kawakami, Hisato, Sakiyama, Tsutomu, Okamoto, Kunio, Tanaka, Kaoru, Takeda, Masayuki, Kaneda, Hiroyasu, Nishina, Shin-ichi, Tsurutani, Junji, Fujiwara, Kimiko, Nomura, Morihiro, Yamazoe, Yuzuru, Chiba, Yasutaka, Nishida, Shozo, Tamura, Takao, Nakagawa, Kazuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096506/ https://www.ncbi.nlm.nih.gov/pubmed/25020203 http://dx.doi.org/10.1371/journal.pone.0101902 |
Ejemplares similares
-
Increased risk of SSEs in bone-only metastatic breast cancer patients treated with zoledronic acid
por: Yanae, Masashi, et al.
Publicado: (2017) -
Phase I study of amatuximab, a novel monoclonal antibody to mesothelin, in Japanese patients with advanced solid tumors
por: Fujisaka, Yasuhito, et al.
Publicado: (2014) -
Phase 1 study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced solid tumors
por: Shimizu, Toshio, et al.
Publicado: (2016) -
Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway
por: Kidera, Yasuhiro, et al.
Publicado: (2010) -
Heregulin-expressing HER2-positive breast and gastric cancer exhibited heterogeneous susceptibility to the anti-HER2 agents lapatinib, trastuzumab and T-DM1
por: Nonagase, Yoshikane, et al.
Publicado: (2016)